American Association for Cancer Research

Latest stories

15d
Business Wire
Immunovaccine Announces Financial Results for Quarter Ended June 30, 2015HALIFAX, Nova Scotia--(BUSINESS WIRE)--Immunovaccine Inc. (“Immunovaccine” or t
Immunovaccine Announces Financial Results for Quarter Ended June 30, 2015
Business Wire / Posted 15 days ago
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Immunovaccine Inc. (“Immunovaccine” or the “Company”) (TSX: IMV; OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy company, today released its financial and operational results for the second quarter... Read more
16d
News-Medical-Net
Researcher study potential biomarker to determine patients at risk for aggressive breast cancerBiomarkers are an important part in detecting certain cancers such as the BRCA
Researcher study potential biomarker to determine patients at risk for aggressive breast cancer
News-Medical-Net / Posted 16 days ago
Biomarkers are an important part in detecting certain cancers such as the BRCA gene in breast cancer and the PSA antigen in prostate cancer. They are easy to identify in a blood test and can help in diagnosing and giving a prognosis. Biomarkers help... Read more
17d
Business Wire
BioTime, Inc. Reports Second Quarter 2015 Results and Recent DevelopmentsALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today reported f
BioTime, Inc. Reports Second Quarter 2015 Results and Recent Developments
Business Wire / Posted 17 days ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today reported financial results for the second quarter ended June 30, 2015 and provided a corporate update. “BioTime’s management team has sharpened its focus on our high priority... Read more
17d
News-Medical-Net
CRI to honor three scientists for contributions to immunology and cancer immunotherapy researchThe Cancer Research Institute (CRI), a nonprofit organization dedicated to fuel
CRI to honor three scientists for contributions to immunology and cancer immunotherapy research
News-Medical-Net / Posted 17 days ago
The Cancer Research Institute (CRI), a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, will bestow its highest honors on three scientists who have made fundamental contributions to... Read more
21d
express
Spice up your life: Research shows hot food reduces cancer risk IF VARIETY is the spice of life then spice is an aid to life itself. New res
Spice up your life: Research shows hot food reduces cancer risk
express / Posted 21 days ago
IF VARIETY is the spice of life then spice is an aid to life itself. New research revealed that eating hot food three times a week lowers the risk of early death Never mind an apple a... Read more
23d
News-Medical-Net
Top cancer research organizations to sponsor International Cancer Immunotherapy Conference in New YorkThe Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (
Top cancer research organizations to sponsor International Cancer Immunotherapy Conference in New York
News-Medical-Net / Posted 23 days ago
The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will join forces to sponsor the first International Cancer... Read more
27d
express
Just 15 minutes exercise a day as a teenager can help women live longer, study finds GIRLS who do just 15 minutes of exercise a day in their teens are less likely
Just 15 minutes exercise a day as a teenager can help women live longer, study finds
express / Posted 27 days ago
GIRLS who do just 15 minutes of exercise a day in their teens are less likely to die from cancer and other causes in later life, a study has found. Exercising as a... Read more
10 related stories
28d
New Kerala
Teenage workouts may lower death risk in later life Regular exercise during adolescence may lower death risk in middle and older
Teenage workouts may lower death risk in later life
New Kerala / Posted 28 days ago
Regular exercise during adolescence may lower death risk in middle and older age from all causes, including cancer, especially in women,a study has said. "Understanding the long-term impact of... Read more
10 related stories
30d
PR.com
Strathmore�s Who�s Who Honors Susan J. Littman, M.D. as Professional of the Year Susan J. Littman, of Maple Glen, Pennsylvania, was recognized as a 2015 Profe
Strathmore�s Who�s Who Honors Susan J. Littman, M.D. as Professional of the Year
PR.com / Posted 30 days ago
Susan J. Littman, of Maple Glen, Pennsylvania, was recognized as a 2015 Professional of the Year by Strathmore�s Who�s Who for her outstanding contributions and... Read more
30d
Business Wire
Give Back While Banking? Fifth Third Bank Pledges Support to Stand Up to CancerFifth Third Bank will support Stand Up To Cancer (SU2C) in a promotion that all
Give Back While Banking? Fifth Third Bank Pledges Support to Stand Up to Cancer
Business Wire / Posted 30 days ago
Fifth Third Bank will support Stand Up To Cancer (SU2C) in a promotion that allows new bank customers to help fight cancer when they open Essential Checking Accounts. The promotion, at 53.com/howifight, follows the national trend of companies giving... Read more
30d
News-Medical-Net
Research brief provides clinical validation of LOXO-101 Phase 1 trial for treatment of TRK fusion cancerPeer-Reviewed Research Brief Published in Cancer Discovery First Confirmed Pati
Research brief provides clinical validation of LOXO-101 Phase 1 trial for treatment of TRK fusion cancer
News-Medical-Net / Posted 30 days ago
Peer-Reviewed Research Brief Published in Cancer Discovery First Confirmed Patient Response The University of Colorado Cancer Center and Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the discovery, development and... Read more
30d
News-Medical-Net
Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trialThe University of Colorado Cancer Center and Loxo Oncology, Inc. (Nasdaq:LOXO),
Research brief describes enrollment of first patient with TRK fusion cancer in LOXO-101 Phase 1 trial
News-Medical-Net / Posted 30 days ago
The University of Colorado Cancer Center and Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the discovery, development and commercialization of targeted cancer therapies, today announced the publication of a research brief... Read more
m
The Daily Guardian
USA professors receive Balik Scientist AwardsTWO US-trained scientists of the University of San Agustin (USA) were recipient
USA professors receive Balik Scientist Awards
The Daily Guardian / Posted 1 months ago
TWO US-trained scientists of the University of San Agustin (USA) were recipients of the Department of Science and Technology’s Balik Scientist Program (BSP) Awards. They are Dr. Doralyn S. Dalisay, professor in the Department of Pharmacy, and Dr.... Read more

People in this news